Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Algorithm to Stratify Clinical Decompensation Risk in Patients With Compensated Advanced Chronic Liver Disease (CHESS2108)

NCT05100485 is registered in ClinicalTrials.gov with Hepatopancreatobiliary Surgery Institute of Gansu Province as lead sponsor.

NCT NCT05100485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05100485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Algorithm to Stratify Clinical Decompensation Risk in Patients With Compensated Advanced Chronic Liver Disease (CHESS2108)
Lead sponsor
Hepatopancreatobiliary Surgery Institute of Gansu Province
Phase
Observational
Overall status
Completed
Start date
January 1, 2022
Completion date
January 1, 2023
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

compensated advanced chronic liver disease